Riluzole attenuates excitatory amino acid transporter type 3 activity in Xenopus oocytes via protein kinase C inhibition

European Journal of Pharmacology

Volumn 713, Issue 1-3, 2013, Pages 39-43

  Choi, Jung Seok ^a   Ryu, Jung Hee ^b   Zuo, Zhiyi ^c   Yang, Seong Mi ^d   Chang, Hye Won ^b   Do, Sang Hwan ^b  

^a Seoul National University Boramae Hospital   (South Korea)

^b Seoul National University Bundang Hospital   (South Korea)

^c UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^d Seoul National University Hospital   (South Korea)

Author keywords

EAAT3; Glutamate transporter; Protein kinase C; Riluzole; Xenopus oocyte

Indexed keywords

CHELERYTHRINE; EXCITATORY AMINO ACID TRANSPORTER 3; GLUTAMIC ACID; MESSENGER RNA; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C; RILUZOLE; STAUROSPORINE;

ANIMAL CELL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ACTIVITY; ELECTRIC POTENTIAL; ELECTRODE; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; MEMBRANE CURRENT; NONHUMAN; OOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; XENOPUS;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; EXCITATORY AMINO ACID ANTAGONISTS; EXCITATORY AMINO ACID TRANSPORTER 3; MICROINJECTIONS; OOCYTES; PROTEIN KINASE C; RILUZOLE; RNA, MESSENGER; TRANSCRIPTION, GENETIC; XENOPUS LAEVIS;

EID: 84878301775     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2013.04.048     Document Type: Article

References (29)

1. M.C. Bellingham A review of the neural mechanisms of action and clinical efficiency of riluzole in treating amyotrophic lateral sclerosis: what have we learned in the last decade? CNS Neurosci. Ther. 17 2011 4 31
2. L.I. Bruijn, T.M. Miller, and D.W. Cleveland Unraveling the mechanisms involved in motor neuron degeneration in ALS Annu. Rev. Neurosci. 27 2004 723 749
3. M. Carbone, S. Duty, and M. Rattray Riluzole elevates GLT-1 activity and levels in striatal astrocytes Neurochem. Int. 60 2012 31 38
4. N.C. Danbolt Glutamate uptake Prog. Neurobiol. 65 2001 1 105
5. K.E. Davis, D.J. Straff, E.A. Weinstein, P.G. Bannerman, D.M. Correale, J.D. Rothstein, and M.B. Robinson Multiple signaling pathways regulate cell surface expression and activity of the excitatory amino acid carrier 1 subtype of Glu transporter in C6 glioma J. Neurosci. 18 1998 2475 2485
6. S.H. Do, H.Y. Fang, B.M. Ham, and Z. Zuo The effects of lidocaine on the activity of glutamate transporter EAAT3: the role of protein kinase C and phosphatidylinositol 3-kinase Anesth. Analg. 95 2002 1263 1268 (table of contents)
7. S.H. Do, G.L. Kamatchi, J.M. Washington, and Z. Zuo Effects of volatile anesthetics on glutamate transporter, excitatory amino acid transporter type 3: the role of protein kinase C Anesthesiology 96 2002 1492 1497
8. A. Doble The pharmacology and mechanism of action of riluzole Neurology 47 1996 S233 S241
9. J. Dunlop, H. Beal McIlvain, Y. She, and D.S. Howland Impaired spinal cord glutamate transport capacity and reduced sensitivity to riluzole in a transgenic superoxide dismutase mutant rat model of amyotrophic lateral sclerosis J. Neurosci. 23 2003 1688 1696
10. E. Foran, and D. Trotti Glutamate transporters and the excitotoxic path to motor neuron degeneration in amyotrophic lateral sclerosis Antioxid. Redox Signal. 11 2009 1587 1602
11. E. Fumagalli, M. Funicello, T. Rauen, M. Gobbi, and T. Mennini Riluzole enhances the activity of glutamate transporters GLAST, GLT1 and EAAC1 Eur. J. Pharmacol. 578 2008 171 176
12. M.I. Gonzalez, P.G. Bannerman, and M.B. Robinson Phorbol myristate acetate-dependent interaction of protein kinase Calpha and the neuronal glutamate transporter EAAC1 J. Neurosci. 23 2003 5589 5593
13. M.I. Gonzalez, and M.B. Robinson Protein kinase C-dependent remodeling of glutamate transporter function Mol. Interv. 4 2004 48 58
14. G.J. Groeneveld, H.J. Van Kan, S. Kalmijn, J.H. Veldink, H.J. Guchelaar, J.H. Wokke, and L.H. Van den Berg Riluzole serum concentrations in patients with ALS: associations with side effects and symptoms Neurology 61 2003 1141 1143
15. J.M. Herbert, J.M. Augereau, J. Gleye, and J.P. Maffrand Chelerythrine is a potent and specific inhibitor of protein kinase C Biochem. Biophys. Res. Commun. 172 1990 993 999
16. L. Lacomblez, G. Bensimon, P.N. Leigh, P. Guillet, and V. Meininger Dose-ranging study of riluzole in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis/Riluzole Study Group II Lancet 347 1996 1425 1431
17. A.Y. Liu, R. Mathur, N. Mei, C.G. Langhammer, B. Babiarz, and B.L. Firestein Neuroprotective drug riluzole amplifies the heat shock factor 1 (HSF1)- and glutamate transporter 1 (GLT1)-dependent cytoprotective mechanisms for neuronal survival J. Biol. Chem. 286 2011 2785 2794
18. J.S. Nixon, J. Bishop, D. Bradshaw, P.D. Davis, C.H. Hill, L.H. Elliott, H. Kumar, G. Lawton, E.J. Lewis, and M. Mulqueen The design and biological properties of potent and selective inhibitors of protein kinase C Biochem. Soc. Trans. 20 1992 419 425
19. K.M. Noh, J.Y. Hwang, H.C. Shin, and J.Y. Koh A novel neuroprotective mechanism of riluzole: direct inhibition of protein kinase C Neurobiol. Dis. 7 2000 375 383
20. K.M. Noh, Y.H. Kim, and J.Y. Koh Mediation by membrane protein kinase C of zinc-induced oxidative neuronal injury in mouse cortical cultures J. Neurochem. 72 1999 1609 1616
21. R.D. O'Shea Roles and regulation of glutamate transporters in the central nervous system Clin. Exp. Pharmacol. Physiol. 29 2002 1018 1023
22. M. Rattray, and C. Bendotti Does excitotoxic cell death of motor neurons in ALS arise from glutamate transporter and glutamate receptor abnormalities? Exp. Neurol. 201 2006 15 23
23. J.D. Rothstein, M. Van Kammen, A.I. Levey, L.J. Martin, and R.W. Kuncl Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis Ann. Neurol. 38 1995 73 84
24. J. Ryu, I.Y. Cheong, S.H. Do, and Z. Zuo Alphaxalone, a neurosteroid anaesthetic, increases the activity of the glutamate transporter type 3 expressed in Xenopus oocytes Eur. J. Pharmacol. 602 2009 23 27
25. K.D. Sims, and M.B. Robinson Expression patterns and regulation of glutamate transporters in the developing and adult nervous system Crit. Rev. Neurobiol. 13 1999 169 197
26. K. Sobczak, N. Bangel-Ruland, G. Leier, and W.M. Weber Endogenous transport systems in the Xenopus laevis oocyte plasma membrane Methods 51 2010 183 189
27. S.F. Steinberg Structural basis of protein kinase C isoform function Physiol. Rev. 88 2008 1341 1378
28. S.J. Wang, K.Y. Wang, and W.C. Wang Mechanisms underlying the riluzole inhibition of glutamate release from rat cerebral cortex nerve terminals (synaptosomes) Neuroscience 125 2004 191 201
29. J.Y. Yun, J.H. Kim, H.K. Kim, Y.J. Lim, S.H. Do, and Z. Zuo Effects of intravenous anesthetics on the activity of glutamate transporter EAAT3 expressed in Xenopus oocytes: evidence for protein kinase C involvement Eur. J. Pharmacol. 531 2006 133 139